Leading graphene developer XG Sciences signs licensing agreement with Cabot; will other multinationals join the fray?

November 07, 2011 | Analyst Insight

Leading graphene developer XG Sciences (see the August 15, 2011 LRMJ) recently announced a $4 million licensing agreement with Cabot Corporation. In addition to granting Cabot non-exclusive right to its graphene nanoplatelet (GNP) manufacturing technology, XG plans...